Results 71 to 80 of about 15,060 (265)

Onychoscopy in Palmoplantar Psoriasis: A Comparative Study of Nonpustular Palmoplantar Psoriasis and Palmoplantar Pustulosis

open access: yesDermatology Practical & Conceptual
Introduction: Palmoplantar psoriasis (PP) is classified as nonpustular psoriasis (NPPP) or palmoplantar pustulosis (PPP). Objective: We sought to shed light on the phenotypic diversity of nail psoriasis (NP) and conducted a thorough study of the ...
Ahu Yorulmaz
doaj   +1 more source

Tinea capitis due to Trichophyton tonsurans in a Maltese patient [PDF]

open access: yes, 2014
We report a case of tinea capitis caused by Trichophyton tonsurans in a 16-year-old male. This appears to be the first documented case of tinea capitis caused by this dermatophyte in a native Maltese patient.peer ...
Baldacchino, Godfrey   +3 more
core  

The interleukin 1 receptor antagonist anakinra to reduce disease severity of palmoplantar pustulosis in adults: APRICOT RCT and PLUM mechanistic study

open access: yesEfficacy and Mechanism Evaluation, 2022
Background: Palmoplantar pustulosis is a rare, debilitating, chronic skin disease involving the hands and feet, and there are limited treatment options. Mechanistic findings suggest that interleukin 1 may be a pathogenic driver.
Suzie Cro   +12 more
doaj   +1 more source

Assessing the Effect of Adalimumab in Granuloma Annulare: A Case Series and Literature Review

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Granuloma annulare (GA) is a benign granulomatous skin disorder for which standardized treatment guidelines are lacking due to limited evidence. Adalimumab, a TNF‐α inhibitor, shows promise as a therapeutic option due to its potential to disrupt GA granulomas.
Adriana Caixinha Valorenzos   +2 more
wiley   +1 more source

Association of Clinical and Demographic Factors With the Severity of Palmoplantar Pustulosis

open access: yesJAMA dermatology, 2020
Key Points Question Are clinical and demographic factors associated with the severity of palmoplantar pustulosis? Findings In a cross-sectional study of 203 patients in the UK, the Palmoplantar Pustulosis Psoriasis Area Severity Index score was ...
Natashia Benzian-Olsson   +30 more
semanticscholar   +1 more source

Successful Use of Bimekizumab in Refractory Acute Generalised Exanthematous Pustulosis Triggered by Amoxicillin‐Clavulanate

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Acute generalised exanthematous pustulosis (AGEP) is a rare, acute neutrophilic dermatosis most commonly triggered by drugs, which typically resolves within 2 weeks following withdrawal of the causative agent. Topical and systemic corticosteroids remain the standard treatment.
Alexandra Junge   +5 more
wiley   +1 more source

Research progress on phosphodiesterase 4 inhibitors in the treatment of palmoplantar pustulosis

open access: yesPifu-xingbing zhenliaoxue zazhi
Palmoplantar pustulosis (PPP) is a chronic recurrent inflammatory skin disease. Existing therapeutic methods cannot meet the demand by patients. Phosphodiesterase-4 (PDE-4) is a key enzyme involved in the balance of immunocytes.
YAO Xinyi   +3 more
doaj   +1 more source

PUSTULOSIS SUBCORNEALIS

open access: yesPraxis medica, 2004
<p>Pustulosis subcornealis is a chronic recurrent disorder with primarly sterile pustular lesion, initially bean-sized. The initial distribution is symmetrical and disseminated. The pustules is affected the trunk and the proximal extremities. A rare condition, affecting women.
M. Relić, J. Živanović
openaire   +1 more source

Efficacy of guselkumab in a subpopulation with pustulotic arthro‐osteitis through week 52: an exploratory analysis of a phase 3, randomized, double‐blind, placebo‐controlled study in Japanese patients with palmoplantar pustulosis

open access: yesJournal of the European Academy of Dermatology and Venereology, 2020
Previous studies of guselkumab have demonstrated clinical benefits in patients with plaque‐type psoriasis, generalized pustular psoriasis, erythrodermic psoriasis and palmoplantar pustulosis (PPP).
Toshiyuki Yamamoto   +7 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy